Highlights

• Anthem Biosciences shares gained over 4% during Thursday’s trading session.
• A large block deal worth nearly ₹1,275 crore was executed in the stock.
• Around 1.17 crore shares, representing 3.05% of the company’s equity, changed hands.
• Strong market absorption of the transaction helped support investor sentiment.
• The stock touched an intraday high of ₹811.00 before trading near ₹798.50.

Overview

Anthem Biosciences Limited (NSE: ANTHEM) remained in focus after witnessing a substantial block deal involving approximately 1.17 crore shares. Despite the sizeable transaction, the stock moved higher as investors appeared comfortable absorbing the additional supply. The counter traded with elevated volumes and outperformed the broader market, reflecting continued interest in the company's long-term growth prospects and earnings profile.

Block Deal Activity Draws Attention

The primary trigger behind the stock's movement was a major equity transaction worth nearly ₹1,275 crore. Large block deals often attract market attention because they can signal changes in shareholder positioning and create short-term volatility.

In Anthem Biosciences' case, the market reaction remained constructive as the stock advanced after the transaction. The ability of the market to absorb such a large quantity of shares without significant price disruption is often viewed positively by participants tracking liquidity and institutional participation.

Strong Financial Performance Supports Sentiment

Investor confidence has also been supported by the company's recent financial performance. For the quarter ended March 2026, Anthem Biosciences reported total income of ₹64,312.60 lakh, profit before tax of ₹30,072.00 lakh, and net profit of ₹21,166.40 lakh. Earnings per share stood at ₹3.77.

The healthy profitability profile continues to support the company's valuation and growth narrative, particularly as demand for research, development, and manufacturing services remains robust across the pharmaceutical and biotechnology ecosystem.

Market Participants Focus on Growth Visibility

Beyond the block deal, market participants continue to monitor the company's operational execution and expansion opportunities. Investors typically favor businesses that demonstrate strong earnings visibility, scalable operations, and healthy margins.

The latest trading activity suggests that the market remains focused on Anthem Biosciences' longer-term growth trajectory rather than short-term ownership changes.

Technical Perspective

Anthem Biosciences shares opened at ₹784.95 and climbed to an intraday high of ₹811.00 before trading around ₹798.50. The stock remains above key medium-term trend levels, indicating continued positive momentum.

From current levels, immediate support is placed near ₹758.58 and ₹718.65. On the upside, resistance levels are positioned around ₹838.43 and ₹878.35. Sustained trading above resistance zones could keep momentum intact, while a break below support levels may trigger near-term consolidation.

Outlook

The sharp rise in Anthem Biosciences shares highlights the market's positive response to the large block deal and the company's underlying financial strength. While ownership changes can sometimes create temporary pressure, investor sentiment appears supported by strong earnings performance, healthy liquidity, and confidence in future growth opportunities.

FAQ

Why did Anthem Biosciences shares rise today?

The stock gained after a block deal worth nearly ₹1,275 crore was executed, with investors absorbing the large transaction positively.

How many shares changed hands in the block deal?

Approximately 1.17 crore shares, representing around 3.05% of the company's equity, were traded.

What was the block deal value?

The transaction was valued at nearly ₹1,275 crore.

What were Anthem Biosciences' latest quarterly earnings?

For the quarter ended March 2026, the company reported net profit of ₹21,166.40 lakh and earnings per share of ₹3.77.

What levels are investors watching?

Immediate support is near ₹758.58 and ₹718.65, while resistance is located around ₹838.43 and ₹878.35.